FDA advisers vote to include an Omicron-specific component for a coronavirus booster
The U.S. Food and Drug Administration's independent Vaccines and Related Biological Products Advisory Committee voted Tuesday to support recommending inclusion of an Omicron-specific component for a COVID-19 booster vaccine.